loading

Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
16.75%
70.50
84.69 67.85 66.17 67.70
Cost Of Revenue
0.97%
45.28
44.84 47.28 47.36 54.72
Gross Profit
36.68%
25.23
39.84 20.57 18.81 12.99
Operating Expenses
344.99%
176.35
39.63 40.37 43.63 49.54
Benefits Costs and Expenses
177.15%
215.70
77.83 82.55 87.22 101.17
Costs And Expenses
177.15%
215.70
77.83 82.55 87.22 101.17
Operating Income/Loss
70,717%
-151.12
0.214 -19.80 -24.82 -36.55
Income/Loss From Continuing Operations Before Tax
2,217%
-145.20
6.86 -14.70 -21.05 -33.46
Income Tax Expense/Benefit, Deferred
97.41%
0.502
19.38 -3.218 -5.20 -3.346
Income Tax Expense/Benefit
153.44%
-10.86
20.33 -3.11 -5.20 -9.386
Income/Loss From Continuing Operations After Tax
897.58%
-134.33
-13.47 -11.59 -15.85 -24.08
Net Income/Loss
897.58%
-134.33
-13.47 -11.59 -15.85 -24.08
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
1,623%
-6.185
-0.359 -0.361 -0.509 -0.244
Basic Average Shares
100.02%
-0.005
30.01 29.81 29.54 -0.159
Diluted Average Shares
100.02%
-0.005
30.01 29.81 29.54 -0.143
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$111.07
price down icon 2.96%
diagnostics_research LH
$210.59
price down icon 1.19%
diagnostics_research WAT
$355.95
price down icon 1.26%
$314.72
price down icon 0.35%
diagnostics_research MTD
$1,522.75
price down icon 0.51%
diagnostics_research IQV
$231.18
price down icon 1.63%
Capitalizzazione:     |  Volume (24 ore):